Neurobiology of Adolescent Substance Abuse from a Developmental - - PowerPoint PPT Presentation

neurobiology of adolescent substance
SMART_READER_LITE
LIVE PREVIEW

Neurobiology of Adolescent Substance Abuse from a Developmental - - PowerPoint PPT Presentation

Neurobiology of Adolescent Substance Abuse from a Developmental Perspective Deborah R. Simkin, M.D. Clinical Assistant Professor Department of Psychiatry University of Emory School of Medicine 1 Disclosures Pfizer Inc. Research Support


slide-1
SLIDE 1

1

Neurobiology of Adolescent Substance Abuse from a Developmental Perspective

Deborah R. Simkin, M.D. Clinical Assistant Professor Department of Psychiatry University of Emory School of Medicine

slide-2
SLIDE 2

Disclosures

  • Pfizer Inc. Research Support
slide-3
SLIDE 3

Learning Objectives

  • Scope of the problem
  • Developmental vulnerability
slide-4
SLIDE 4

Narcotics other than Heroin: Trends in Annual Use and Availability Grades 8, 10, and 12

  • Source. The Monitoring the Future study, the University of Michigan.
slide-5
SLIDE 5

Narcotics other than Heroin: Trends in Annual Use and Availability Grades 8, 10, and 12

  • Source. The Monitoring the Future study, the University of Michigan.
slide-6
SLIDE 6

Scope of the Problem

Domains of Factors Associated with Drug Use (Newcomb, 1997)

  • I. Cultural/Societal

– Laws favorable to drug use – Social norms favorable to drug use – Availability of drugs – Extreme economic deprivations – Neighborhood disorganization

slide-7
SLIDE 7

Protective Factors

– RESILENCE - Good life events and an internal locus of control seem to cushion the development of substance use disorders in sons of alcoholics (Springer, '95) – stable environment – high degree of motivation – strong parent-child bond consistent parental supervision & discipline – bonding to pro-social institution – association with peers who hold conventional attitudes – consistent community wide anti-drug use messages (Glantz, '98)

slide-8
SLIDE 8

Scope of the Problem Newcomb, 1997

Child and Adolescent Psychobehavioral Influences

  • Age of first use-higher % of those who start <11 yo

met criteria for dependence than those that start 14- 15 yo

  • Rapid progression of SUD occurred with earlier onset

& frequency and not duration of use of substances (DeWitt, ’00, Kandel ’92)

  • Earlier onset had shorter time span between 1st

exposure to dependence than adult onset groups (Clark,’98)

slide-9
SLIDE 9

Scope of the problem

  • ALCOHOL
  • Event Age
  • First drink- 13
  • First drunk -15
  • First problem -18
  • First dependence -25-40
  • Death -60
  • (Schukit, 2000)
  • Therefore, Addiction is a pediatric disease
slide-10
SLIDE 10

Developmental Vulnerability

slide-11
SLIDE 11
  • family
  • history Pre school Kindergarten- 5th grade middle school high school
  • MJH &
  • drinks q d
  • age birth

3-5 5-7 8- 9-10 11-14 15----- 16-17--18__

  • events: -Pare nts separate -Parents
  • Pre-natal -Separation -Untreated -Sexual abuse separate -
  • exposure anxiety ADHD by neighbor again - raped

nicotine and LD while

  • and drunk
  • MJH l -Driving while
  • Hypoxia at birth -Po or grades intoxicated
  • Poor nutrition co ntinue - Stops soccer
  • Cigarette use begins -Begins using
  • marijuana and alcohol
  • and loratab in mom’s
  • medicine cabinet
slide-12
SLIDE 12

Neurobiological insults that increase risk for substance abuse from developmental perspective as seen in case example above

1. Family history

  • Mom (depression), Mat Uncle PTSD died of cirrhosis, Pat GP and Dad alcoholics.

(Cadoret, RJ, etal, Arch of Gen Psychiatry 1986. Kendler, KS, Presscott, CA. Amer. J. Psychiatry 1998)

  • Lower D2 receptors in NaC, seen in families with alcoholism, decreases ability to inhibit

drive to use drugs

2. Prenatal nicotine exposure

  • increased toddler negativity,
  • increased externalizing disorders such as, ADHD or ADHD symptoms and/or conduct

disorders

  • lower IQ and auditory functions

(Niaura, J, et al, Amer J of Addic, 2001. Weissman, MM, et al, JAACP, 1999)

3. Prenatal exposure to MJH-

  • visual working memory deficits
  • inattention
  • short term memory deficits

(Day, N, et al, ADDICTION, 2006. Goldschmidt, L, et al, JAACP 2008. Smith AM, et al, Neurotoxicol Terato, 2006.)

slide-13
SLIDE 13

What causes Adolescents to experiment-role of early development of the Pre Frontal Cortex

  • Casey, et al 2008
slide-14
SLIDE 14
slide-15
SLIDE 15

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • 4. Hypoxia and nutritional deficits=

– increased risk for ADHD and LD

(Stein, MB, et al. Neuropsychopharm, 2008. Levenson, JM, Nat Rev Neurosci. 2005. Koob G & LeMoal M, Annual Rev Psychol, 2008)

Note: for examples # 2, 3 and 4,

– Substance abuse at age 14 or 15 could be predicted by academic and social behavior between the ages of 7 and 9

(Hyman Hops, et al, J Study Alcohol Suppl. 1999)

– Adolescents with attention difficulties not associated with ADHD but with undiagnosed LD’s, predicted substance abuse and dependence eight years later. (Tapert, SF, et al, JAACAP, 2002)

slide-16
SLIDE 16

Neurobiological insults that increase risk for substance abuse from developmental perspective 5. 2006-2008 National Survey on Drug Use and Health. (Fiellin, et al, J Adol Health, 2013)

  • RESULTS:
  • Twelve percent of the survey population of 18-25 year olds (n =

6,496) reported current abuse of prescription opioids.

  • For this population, prevalence of previous substance use was

57% for alcohol, 56% for cigarettes, and 34% for marijuana.

  • Among both men and women, previous marijuana use was 2.5

times more likely than no previous marijuana to be associated with subsequent abuse of prescription opioids.

  • Previous alcohol, cigarette, and marijuana use were each

associated with current abuse of prescription opioids in 18-25- year-old men, but only marijuana use was associated with subsequent abuse of prescription opioids in young women.

slide-17
SLIDE 17

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • 6. Disturbed brain connectivity in cannabis users may

underlie cognitive impairment and vulnerability to psychosis, depression and anxiety disorders (Lim, et al, 2002) and cognitive function (Meier, 2012)

  • A. White matter alterations have been associated

with various functional and clinical outcomes in schizophrenia, including illness, symptomatic and cognitive measures (Walterfang et al, 2011).

  • B. White matter pathology underlying faulty

integration of cortical–cerebellar–thalamic–cortical circuits are thought to play a primary role in the

  • bserved cognitive deficits (Wexler et al, 2009)
slide-18
SLIDE 18

The right fimbria of the hippocampus, hippocampal commissure and splenium comprised fewer streamlines in cannabis users compared to non-users (P < 0.05, corrected).

2 different oblique views. Red areas denote fewer streamlines Zalesky A et al. Brain 2012;135:2245-2255

slide-19
SLIDE 19

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • C. Similar connectivity disturbances, particularly

in the fimbria of the hippocampus and commissural fibres extending to the precuneus have been reported in a study (Zalesky, 2012).

  • The hippocampus appears to have the highest

density of CB1 receptors.

  • This may underlie the memory impairment

and other cognitive deficits that are observed in long-term heavy cannabis users.

slide-20
SLIDE 20

Fewer streamlines interconnected the right precuneus with the splenium in cannabis users compared to non-users (P < 0.05, corrected).

Zalesky A et al. Brain 2012;135:2245-2255

slide-21
SLIDE 21

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • C. Long term use and effect on IQ (Meier, et al, 2012)
  • Association between persistent cannabis use—

prospectively assessed over 20 y—and neuropsychological functioning in a birth cohort of 1,037 individuals.

  • Study members underwent neuropsychological

testing at age 13 y before the onset of cannabis use and again at age 38 y, after some had developed a persistent pattern of cannabis use.

  • Cannabis use was ascertained in interviews at ages

18, 21, 26, 32, and 38 y.

  • Findings:
slide-22
SLIDE 22

Neurobiological insults that increase risk for substance abuse from developmental perspective Findings: 1. More persistent cannabis users did show greater IQ decline, with the most persistent users (n = 41) losing an average of 5–6 IQ points from age 13 y to 38 y 2. Persistent cannabis users showed neuropsychological decline across five different areas of mental function (executive functions, memory, processing speed, perceptual reasoning, and verbal comprehension), indicating that decline is global.

  • Furthermore, this decline was still apparent after controlling

for years of education

  • and after ruling out multiple other alternative explanations

(for example, the decline was not due to persistent dependence on alcohol or other substances).

slide-23
SLIDE 23

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • 3. Adolescent-onset cannabis users who used cannabis

persistently up to age 38 y (n = 23) lost an average of 8 IQ points from age 13 y to 38 y.

  • 4. Cessation of cannabis use did not fully restore functioning

among adolescent-onset cannabis users.

  • Evidence regarding the acute impairments in memory

function induced by cannabis is generally robust, particularly for those using cannabis with a lower proportion of CBD and higher proportion of Δ9-THC (Meier, 2012)

  • The hippocampus appears to have the highest density of CB1

receptors-Higher THC in todays cannabis may cause more neurotoxic effects on the developing brain.

slide-24
SLIDE 24

Neurobiological insults that increase risk for substance abuse from developmental perspective

slide-25
SLIDE 25

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • 7. Stressors –effect on epigenetics (environment and genes)

trauma=sexual abuse, (Jones, DJ, 2012), pre natal exposure, hypoxia

at birth, poor nutrition, early life experiences (parental conflict & separating, poor academics), separation anxiety and social phobia (Deas-Nesmith, D, et al, 1998, Nelson, 2000, Merikangas, et al, 1998)

*Alter addiction pathology later in life:

  • changes gene expression through chromatin remodeling with no

changes in DNA sequences.

  • Ex.= stressors alter expression of genes that dysregulate the

hypothalamic pituitary axis (HPA)

  • thus, increasing sensitivity to stress and increase the risk for using

substances to relieve this stress.

  • Using drugs to relieve stress does the same = vicious cycle

(Stein, MB, et al. Neuropsychopharm, 2008. Levenson, JM, Nat Rev Neurosci. 2005. Koob G & LeMoal M, Annual Rev Psychol, 2008)

slide-26
SLIDE 26

Neurobiological insults that increase risk for substance abuse from developmental perspective

  • 8. CRAFFT- (Knight, JR, et al. Arch Pediatr Adolesc Med, 2002)

(Car, Relax (untreated anxiety), Alone, Friends (role

  • f oxytocin), Forgot, Trouble)
  • 9. Personality: Babor type B-

– early onset of spontaneous alcohol-seeking behavior; – diagnosis during adolescence; rapid course of onset;

– genetic precursors that put them at risk to develop

substance abuse; – severe symptoms of deviant behavior, including fighting, high novelty seeking, low harm avoidance

(Babor, TF, et al. Arch of General Psychiatry 1992. )

slide-27
SLIDE 27

Positive factors

  • 1. Motivation: (Prochaska and DiClemente Psychother

Theory Res Practice 1982)-Motivational Enhancement Therapy (MET)

– precontemplation-denial – contemplation-on a fence-ambivalent – preparation-she was ready to make concrete change plan for change – action-reduces or quits and works treatment plan – maintenance-avoids relapse

  • 2. Supportive mother and no previous CD sx.
slide-28
SLIDE 28

Treatment

She Choose:

  • Meetings 3-5 times per week,
  • vivitrol monthly injection since alcohol was drug of choice,
  • weekly random urine drug screens,
  • avoided friends who used,
  • went back to church youth group,
  • Treated for depression,
  • individual weekly therapy with CBT and reforming positive

identity,

  • got tested for learning disorders and re-entered college

gradually

slide-29
SLIDE 29

Addiction is a Pediatric Disease

  • Importance of early intervention.
  • Ongoing CONTROVERSY:
  • New DSM V diagnostic criteria is developed

for adults and does not take into account developmental issues.

slide-30
SLIDE 30

Table I. Proposed alcohol use disorder criteria from the DSM-V (American Psychiatric Association) Alcohol use disorder is defined as a maladaptive pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least 2 of the following 11 characteristics, occurring within a 12- month period:

  • (1) recurrent alcohol use resulting in a failure to fulfill major role obligations at work, school or home;
  • (2) recurrent alcohol use in situations in which it is physically hazardous;
  • (3) continued alcohol use despite having persistent or recurrent social or interpersonal problems caused
  • r exacerbated by the effects of the substance;
  • (4) tolerance as defined by either (a) a need for markedly increased amounts of alcohol to achieve

intoxication or desired effect or

  • (b) markedly diminished effect with continued use of the same amount of alcohol;
  • (5) withdrawal, as manifested by either (a) the characteristic withdrawal syndrome for alcohol or (b)

alcohol or a closely related substance is taken to relieve or avoid withdrawal symptoms;

  • (6) alcohol is often taken in larger amounts or over a longer period than was intended;
  • (7) there is a persistent desire of unsuccessful efforts to cut down or control alcohol use;
  • (8) a great deal of time is spent in activities necessary to obtain alcohol, use alcohol or recover from its

effects;

  • (9) important social, occupational or recreational activities are given up or reduced because of alcohol

use;

  • (10) alcohol use is continued despite knowledge of having a persistent or recurrent physical or

psychological problem that is likely to have been caused or exacerbated by alcohol;

  • (11) craving or a strong desire or urge to use alcohol
slide-31
SLIDE 31

DSM V Controversy

Beyond the fact that items in bold may not apply to adolescents, another way to distinquish adolescents who may meet DSM V criteria for substance use disorder: Suggestion:

  • Excluding the Hazardous Use criterion (Can Nicotine fit into this criteria),
  • Clarifying the operational definitions of Tolerance (since many teens

increase use periodically but not frequently),

  • Withdrawal and Craving-only 2 sub criteria needed of 8-could be

confused with hangover

  • Unsuccessful attempts to cut down may have been due to coersion and

not due to motivation and

  • Critically evaluating the diagnostic threshold for SUDs in adolescents.
  • Would recognize that using only 2 criteria to diagnose the disorder may

pick up mild cases in adolescents.(Winters, KC, et al. Addiction, 2011)

slide-32
SLIDE 32

What constitutes whether an adolescent may progress?

Adolescent-onset adults, compared with other adult-

  • nset groups:
  • had higher lifetime rates of cannabis and

hallucinogen use disorders,

  • shorter times from first exposure to dependence,
  • shorter times between the development of their first

and second dependence diagnoses and

  • higher rates of disruptive behavior disorders and

major depression.

  • Early onset and frequency, not duration
  • (Clark, DB, et al. Drug Alcohol Dep 1998, DeWitt, 2000, Kandel, 1992)
slide-33
SLIDE 33

Addiction is a Pediatric Disease

Recognition of and Early intervention on risk factors essential to prevention

  • Gateway to use may not just be categorized as

substances of abuse used, but risk factors that lead to drug use

  • Alcohol seems to be most influential as

gateway

  • (Kirby B & Barry, AE, J Sch Health, 2012)
  • So if an adolescent does end up with severe,

frequent, chronic and debilitating use, what can be done?

slide-34
SLIDE 34

1-3 learned behavior

2 3

VTA

Ventral pallidum

Medial Dorsal thalmus

PFC (Ant.cing.& OFC)

Basolateral amygdala

Extended amygdala=

Central amygdala nucleus, bed Nucleus of stria terminalis and Nucleus Accumbens shell

NAc Core

Dopamine Glutamate GABA GABA/Neuropeptide 1

slide-35
SLIDE 35

Neural Circuitry Mediating Drug Seeking

Final Common Pathway

Cue Stress

Ventral Pallidum Nucleus Accumbens core

PFC VTA

Basolateral Amygdala Extended Amygdala- Central amygdala nucleus, Bednucleus of the stria terminalis, nucleus accumbens shell

slide-36
SLIDE 36
  • Substance Abuse is a pediatric disease-Early

intervention for risk factors (Bio-Psych-Social) is crucial.

  • Adolescents is a time of experimentation due to an

undeveloped PFC and the effects of substances of abuse on the developing brain are still being explored.

  • Interventions that most often lead to relapse have to

be explored more extensively in adolescents and converted to positive risk factors

  • Access and availability to opioids is on the rise